Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
1.12
Dollar change
+0.16
Percentage change
16.63
%
IndexRUT P/E- EPS (ttm)-0.83 Insider Own55.45% Shs Outstand253.96M Perf Week20.82%
Market Cap334.40M Forward P/E- EPS next Y-0.84 Insider Trans0.00% Shs Float114.05M Perf Month-5.88%
Income-210.26M PEG- EPS next Q-0.20 Inst Own26.33% Short Float9.43% Perf Quarter-21.13%
Sales0.05M P/S6688.04 EPS this Y9.95% Inst Trans0.51% Short Ratio10.77 Perf Half Y-52.54%
Book/sh2.21 P/B0.51 EPS next Y-0.60% ROA-28.23% Short Interest10.76M Perf Year-32.93%
Cash/sh1.64 P/C0.68 EPS next 5Y-7.90% ROE-32.26% 52W Range0.85 - 3.26 Perf YTD-42.27%
Dividend Est.- P/FCF- EPS past 5Y-15.28% ROI-33.92% 52W High-65.60% Beta-0.48
Dividend TTM- Quick Ratio16.19 Sales past 5Y428.28% Gross Margin-37096.30% 52W Low31.76% ATR (14)0.12
Dividend Ex-Date- Current Ratio16.19 EPS Y/Y TTM1.27% Oper. Margin-425637.04% RSI (14)49.41 Volatility16.53% 10.37%
Employees224 Debt/Eq0.11 Sales Y/Y TTM-99.89% Profit Margin-389368.52% Recom3.33 Target Price1.00
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q29.76% Payout- Rel Volume1.97 Prev Close0.96
Sales Surprise293.94% EPS Surprise8.86% Sales Q/Q-51.85% EarningsAug 07 AMC Avg Volume999.12K Price1.12
SMA202.61% SMA50-10.34% SMA200-40.49% Trades Volume1,965,978 Change16.63%
Date Action Analyst Rating Change Price Target Change
Oct-30-24Downgrade BofA Securities Buy → Underperform $6 → $1
Jun-27-24Downgrade H.C. Wainwright Buy → Neutral $6 → $1
Aug-28-23Downgrade JP Morgan Overweight → Neutral $15 → $5
Nov-14-22Downgrade Morgan Stanley Overweight → Equal-Weight $15 → $7
Nov-11-22Downgrade Goldman Buy → Neutral $13 → $7
Oct-17-22Initiated H.C. Wainwright Buy $12
Jul-12-21Initiated Morgan Stanley Overweight $25
Jul-12-21Initiated JP Morgan Overweight $22
Jul-12-21Initiated Goldman Buy $30
Jul-12-21Initiated BofA Securities Buy $25
Oct-31-24 04:00PM
Oct-30-24 11:16AM
Oct-25-24 11:56AM
Oct-24-24 04:00PM
01:54PM
09:00AM Loading…
Oct-04-24 09:00AM
Sep-24-24 04:05PM
Aug-28-24 04:05PM
Aug-07-24 05:41PM
04:05PM
Aug-06-24 08:00AM
Jun-26-24 02:44PM
07:00AM
Jun-03-24 04:05PM
May-07-24 04:05PM
10:53PM Loading…
May-06-24 10:53PM
01:34PM
08:23AM
08:00AM
Mar-19-24 10:00AM
Mar-07-24 12:00PM
Mar-05-24 04:30PM
Feb-28-24 04:44PM
04:05PM
Feb-26-24 04:05PM
Jan-03-24 04:05PM
Nov-09-23 04:05PM
Nov-07-23 04:33PM
04:05PM
Oct-31-23 09:00AM
09:00AM Loading…
Sep-27-23 09:00AM
Sep-11-23 08:00AM
Aug-31-23 04:05PM
Aug-08-23 07:10PM
04:05PM
Jul-12-23 08:47AM
Jul-05-23 04:05PM
Jun-16-23 10:47AM
Jun-07-23 04:05PM
Jun-01-23 07:55AM
May-04-23 07:25PM
06:25PM
04:05PM
May-02-23 04:05PM
Apr-17-23 07:11AM
Mar-27-23 04:52AM
Mar-26-23 10:14AM
Feb-28-23 08:15PM
04:05PM
Feb-02-23 06:43AM
Jan-03-23 04:05PM
Dec-23-22 06:36AM
Dec-16-22 10:48AM
Dec-15-22 07:00AM
Dec-09-22 09:35AM
Dec-01-22 04:05PM
Nov-12-22 07:39AM
Nov-10-22 04:05PM
06:24AM
Nov-08-22 07:15PM
04:05PM
Nov-07-22 08:05AM
Nov-04-22 10:00AM
Nov-02-22 04:05PM
Oct-25-22 07:59AM
Oct-17-22 12:54PM
09:28AM
Oct-06-22 04:05PM
Oct-05-22 08:05AM
Sep-28-22 04:05PM
Sep-15-22 09:40AM
Sep-12-22 09:55AM
03:00AM
Aug-30-22 04:05PM
Aug-26-22 09:55AM
Aug-10-22 09:55AM
Aug-08-22 06:30AM
Aug-04-22 06:25PM
04:05PM
Jul-17-22 09:49AM
Jun-30-22 01:08PM
Jun-17-22 07:38AM
Jun-07-22 04:05PM
May-25-22 03:00PM
May-10-22 04:05PM
10:45AM
May-09-22 11:29AM
May-05-22 09:31AM
May-04-22 04:05PM
10:52AM
May-03-22 09:55AM
May-02-22 04:30PM
Mar-29-22 04:05PM
Mar-20-22 08:02AM
Mar-16-22 06:26AM
Mar-08-22 04:45PM
Feb-17-22 04:38PM
Jan-31-22 04:05PM
Jan-24-22 12:39PM
08:00AM
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.